Protocol Number:
AEWS1031
Study Name:
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamiae to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AEWS1221
Study Name:
Randomized Phase 2 Trial Evaluating the Addition of the IGF-lR Monoclonal Antibody Ganitumab (AMG479, NSC#750008, IND#120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Age Group:
Pediatrics
Background Information:
See full details